VASCULAR BIOGENICS LTD's ticker is VBLT and the CUSIP is M96883109. A total of 27 filers reported holding VASCULAR BIOGENICS LTD in Q2 2017. The put-call ratio across all filers is 0.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $2,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
| Q1 2018 | $2,000 | -71.4% | 1,000 | 0.0% | 0.00% | -100.0% |
| Q4 2017 | $7,000 | +16.7% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $6,000 | +50.0% | 1,000 | 0.0% | 0.00% | – |
| Q2 2017 | $4,000 | -33.3% | 1,000 | 0.0% | 0.00% | -100.0% |
| Q1 2017 | $6,000 | +20.0% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $5,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 860,605 | $3,830,000 | 5.08% |
| TURNER INVESTMENTS LLC | 41,691 | $186,000 | 0.12% |
| MENTA CAPITAL LLC | 99,935 | $445,000 | 0.05% |
| Migdal Insurance & Financial Holdings Ltd. | 396,726 | $1,765,000 | 0.04% |
| First Eagle Investment Management, LLC | 655,574 | $2,917,000 | 0.01% |
| ETF MANAGERS GROUP, LLC | 14,680 | $65,000 | 0.01% |
| Burt Wealth Advisors | 1,674 | $7,000 | 0.01% |
| Alyeska Investment Group, L.P. | 83,333 | $371,000 | 0.00% |
| MACQUARIE GROUP LTD | 330,000 | $1,469,000 | 0.00% |
| FRANKLIN RESOURCES INC | 452,677 | $2,014,000 | 0.00% |